Find the right patients for your neurology trial

By leveraging relationships with leading neurology centers, Velocity provides greater access to leading investigators and special patient populations. Several of Velocity’s principal investigators are region-leading providers for neurological disorders like Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis.

This specialized expertise reinforces compliant trial conduct and long-term patient assessment. Velocity also maintains well-established patient databases that include sensitive and hard-to-recruit neurological cohorts. Active practice databases are particularly valuable for rare/orphan disease research programs and for reaching patients that may consider a clinical trial as a care option.


Therapeutic expertise

  • Alzheimer’s disease
  • Amyloidosis
  • Depression
  • Epilepsy, idiopathic generalized epilepsy (IGE)
  • Essential Tremors
  • Hereditary transthyretin amyloidosis
  • Huntington’s disease
  • Hypersomnia
  • Insomnia
  • Ischemic stroke
  • Memory impairment
  • Migraine
  • Mild cognitive impairment (MCI)
  • Multiple sclerosis
  • Muscular dystrophy
  • Neurocognitive function with high cholesterol and CV risk
  • No-restorative sleep
  • Organic brain syndrome
  • Pain management
  • Parkinson’s disease
  • Restless legs syndrome
  • Sleep apnea
  • Tourette syndrome

Previous clinical trial experience

  • Migraine
  • Alzheimer’s disease
  • Insomnia
  • Parkinson’s disease
  • And more

Leading sites and neurologists to support groundbreaking research

Beyond neurology sites, Velocity has dedicated research centers and general medicine sites that support high-volume trials for more common conditions, such as migraines and depression. Velocity will align you with the right patients and investigators in the ideal care setting for your trial.

For even the most complex neurology research programs – including those that require overnight and extended day capabilities, you can trust Velocity to provide above-and-beyond recruitment support and procedural continuity.

Let's talk about your next trial